NEA Management Company LLC Has $304.85 Million Stake in Tempus AI, Inc. (NASDAQ:TEM)

NEA Management Company LLC grew its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 17.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,385,979 shares of the company's stock after purchasing an additional 813,169 shares during the period. Tempus AI makes up about 16.6% of NEA Management Company LLC's holdings, making the stock its 2nd biggest position. NEA Management Company LLC owned approximately 3.49% of Tempus AI worth $304,846,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of TEM. Novo Holdings A S acquired a new position in shares of Tempus AI during the second quarter valued at approximately $142,605,000. Revolution Growth Management Company Inc. acquired a new position in Tempus AI in the second quarter worth about $128,133,000. ARK Investment Management LLC grew its stake in shares of Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock valued at $134,604,000 after purchasing an additional 1,855,459 shares during the last quarter. Alphabet Inc. bought a new position in Tempus AI in the second quarter valued at approximately $54,289,000. Finally, Sumitomo Mitsui Trust Group Inc. raised its holdings in Tempus AI by 1,591.2% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the period.

Tempus AI Price Performance

TEM traded down $0.39 on Friday, hitting $62.59. The company had a trading volume of 445,119 shares, compared to its average volume of 1,558,757. The company has a fifty day simple moving average of $53.15. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Stifel Nicolaus lowered shares of Tempus AI from a "buy" rating to a "hold" rating and lifted their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. JPMorgan Chase & Co. boosted their target price on shares of Tempus AI from $42.00 to $47.00 and gave the stock an "overweight" rating in a report on Wednesday, August 7th. Bank of America lowered shares of Tempus AI from a "buy" rating to a "neutral" rating and increased their target price for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Needham & Company LLC restated a "buy" rating and set a $47.00 price objective on shares of Tempus AI in a report on Wednesday, August 7th. Finally, Loop Capital increased their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a report on Tuesday, October 15th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $54.22.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.